Mitchall Clark

Mitch was formerly Chief Regulatory /Quality, Atara Biotherapeutics; SVP Regulatory Affairs, Nantworks; and SVP Regulatory affairs at Abraxis Bioscience where he was responsible for global approvals for Abraxane® and regulatory for early stage to post-marketing of nab products. He has 30+ yrs in international regulatory affairs with Schering AG, FH Faulding/Purepac & APP/Abraxis, Clinical and Manufacturing QA, drug safety and clinical operation.